David M. Berman - Jan 2, 2024 Form 3 Insider Report for Immunocore Holdings plc (IMCR)

Role
Head of R&D
Signature
/s/ David Berman
Stock symbol
IMCR
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
3
Date filed
1/2/2024, 04:43 PM
Next filing
Feb 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMCR Employee Share Option (Right to Buy) Jan 2, 2024 Ordinary Shares 392K $17.46 Direct F1
holding IMCR Employee Share Option (Right to Buy) Jan 2, 2024 Ordinary Shares 469K $26.00 Direct F2
holding IMCR Employee Share Option (Right to Buy) Jan 2, 2024 Ordinary Shares 134K $24.66 Direct F3
holding IMCR Employee Share Option (Right to Buy) Jan 2, 2024 Ordinary Shares 90.6K $64.53 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 25% of the shares subject to the option award vested on February 4, 2022, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F3 25% of the shares subject to the option award vested on February 16, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F4 25% of the shares subject to the option award shall vest on February 16, 2024, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney